Trans Genic Inc. (2342.T)
JPY 181.0
(0.56%)
JPY 181.0
(0.56%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 13.08 Billion JPY | 14.47% |
| 2022 | 11.42 Billion JPY | -9.12% |
| 2021 | 12.57 Billion JPY | 13.85% |
| 2020 | 11.04 Billion JPY | 0.0% |
| 2019 | 11.04 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.88 Billion JPY | -13.72% |
| 2023 Q2 | 3.09 Billion JPY | -5.6% |
| 2023 FY | 13.08 Billion JPY | 14.47% |
| 2023 Q3 | 3.36 Billion JPY | 8.68% |
| 2023 Q1 | 3.28 Billion JPY | 10.62% |
| 2023 Q4 | 3.34 Billion JPY | -0.75% |
| 2022 Q3 | 2.92 Billion JPY | -4.88% |
| 2022 FY | 11.42 Billion JPY | -9.12% |
| 2022 Q4 | 2.96 Billion JPY | 1.5% |
| 2022 Q2 | 3.07 Billion JPY | 0.0% |
| 2021 FY | 12.57 Billion JPY | 13.85% |
| 2020 FY | 11.04 Billion JPY | 0.0% |
| 2019 FY | 11.04 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | -174.281% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -11485.869% |
| GNI Group Ltd. | 26.01 Billion JPY | 49.699% |
| Linical Co., Ltd. | 12.3 Billion JPY | -6.302% |
| MEDINET Co., Ltd. | 661.54 Million JPY | -1877.718% |
| Soiken Holdings Inc. | 5.15 Billion JPY | -153.631% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | -738.475% |
| AnGes, Inc. | 152.98 Million JPY | -8452.118% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | -2044.414% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | -2.487% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | -1501.989% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -9555.119% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | -704.696% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | -2954.285% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | -588.168% |
| Chiome Bioscience Inc. | 682.46 Million JPY | -1817.091% |
| Kidswell Bio Corporation | 2.43 Billion JPY | -438.14% |
| PeptiDream Inc. | 28.71 Billion JPY | 54.432% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -20654.875% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -10712.775% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -18171369.444% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -32701.309% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | -190.064% |
| FunPep Company Limited | 530 Thousand JPY | -2468476.981% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -18793.08% |
| Stella Pharma Corporation | 269.49 Million JPY | -4754.878% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | -4029.645% |
| Cuorips Inc. | 23.1 Million JPY | -56533.443% |
| K Pharma,Inc. | 1 Billion JPY | -1208.346% |
| Takara Bio Inc. | 43.5 Billion JPY | 69.927% |
| ReproCELL Incorporated | 2.42 Billion JPY | -439.12% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | -662.741% |
| StemCell Institute Inc. | 2.48 Billion JPY | -427.305% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | -420.385% |
| CellSeed Inc. | 190.13 Million JPY | -6781.177% |